Tressie McMillan Cottom, Jessica Grose and Meher Ahmad on why plastic surgery and fillers no longer feel like a secret — or a ...
Who's Line Is It Anyway?'s long-running performer—was diagnosed with a detached retina, prompting him to seek emergency eye ...
The potential dangers associated with the use of Botox include “temporary weakness, asymmetry, headaches, or eyelid drooping ...
It doesn’t take an eagle-eyed observer to notice certain similarities among the individuals in Donald Trump’s inner circle: ...
FDA approvals in 2025 introduced novel therapies and devices across ophthalmic subspecialties, emphasizing sustained efficacy ...
W hen diagnosed with diabetic macular edema (DME) in 2017, Sarah Castaneda, 41, thought she would lose her eyesight completely. At least, that’s what her doctor told her would happen if she didn’t ...
Temporarily shutting down a "lazy eye" triggers a burst of neuronal activity that reverses the condition in animal experiments, a study shows. When you purchase through links on our site, we may earn ...
What Is Eylea HD, and Why Does It Matter? Eylea HD (aflibercept) is an injectable medicine used to treat certain eye conditions that can lead to vision loss. It works by blocking a protein called VEGF ...
On Wednesday, the U.S. Food and Drug Administration (FDA) approved Regeneron Pharmaceuticals Inc.’s (NASDAQ: REGN) Eylea HD (aflibercept) Injection 8 mg for patients with macular edema following ...
The approvals come as a pleasant surprise for Regeneron, analysts say, helping bolster the overall product profile of high-dose Eylea despite outstanding manufacturing concerns. Regeneron’s high-dose ...
Shares of the gene therapy developer rose 12.5% to $9.55 in premarket trading on Monday after the news. Sign up here. Under the deal, MeiraGTx will get an upfront payment of $75 million and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback